# Observational Uterine Cervical cancer studies: 114 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 114 trials that are observational for Uterine Cervical cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Uterine Cervical cancer studies: 114 rows for $5.70, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/uterine-cervical-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 114
- Recruiting or not yet: 114
- Read on: November 19, 2026

## Trials

The 25 newest of 114, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 16, 2026 | NCT07938385 | Characterisation of Immunological and Molecular Changes Evolving in Patients Undergoing Radiotherapy (CHIMERA) | Royal Marsden NHS Foundation Trust | Observational | Recruiting | Impact of the Immune Cell Repertoire on the Therapeutic Index of Radiotherapy, The Need for Serum Markers of... | 94 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07938385) |
| November 10, 2026 | NCT07929246 | High-risk HPV Testing With Pap Smear Triage for Cervical Cancer Screening in Women Aged 50 and Older in Ethiopia | University Medical Center Groningen | Observational | Not yet recruiting | Uterine Cervical Neoplasms, Papillomavirus Infections, Uterine Cervical Dysplasia | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07929246) |
| October 27, 2026 | NCT07897786 | Clinical Audit of Cervical Cytology Services in an Early Cancer Detection Unit | Assiut University | Observational | Not yet recruiting | Cervical Intraepithelial Neoplasia, Uterine Cervical Neoplasms, Cervical Precancerous Lesions, Cervical Dysplasia | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07897786) |
| October 20, 2026 | NCT07883798 | Radiotherapy for Gynecologic Cancer With Up to 10 Active Metastatic Lesions | Affidea Nu-med Center of Oncological DIagnostics and Therapy | Observational | Recruiting | Cervical Cancer, Gynecologic Cancer, Endometrial Cancer, Uterine Cancer, Uterine Sarcoma, Ovarian Cancer, Fallopian... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07883798) |
| September 11, 2026 | NCT07816263 | Guaraná Supplementation for Cancer-Related Fatigue | Sponsor not shown (see the record) | Observational | Recruiting | Cancer-related Fatigue, Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Cervical Cancer, Quality of Life | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07816263) |
| September 1, 2026 | NCT07796672 | Feasibility Study of Blood Biomarker Identification in Cervical Cancer | Queensland Centre for Gynaecological Cancer | Observational | Recruiting | Cervical Adenocarcinoma, Cervical Squamous Cell Carcinoma | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07796672) |
| August 24, 2026 | NCT07782697 | Postoperative ctHPV-DNA for Recurrence Prediction and Adjuvant Treatment Decision-Making in Cervical Cancer | Anhui Provincial Hospital | Observational | Not yet recruiting | Cervical Cancer, HPV DNA | 580 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07782697) |
| August 24, 2026 | NCT07782164 | Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study) | Amsterdam UMC, location VUmc | Observational | Recruiting | Colorectal Carcinoma, Renal Cancer, Bladder Cancer, Cervical Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer... | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07782164) |
| August 3, 2026 | NCT07741435 | Methylation Profile Test (Methylscape) in Body Fluids for Multi-Cancer Detection and Monitoring in Colombia | Sponsor not shown (see the record) | Observational | Recruiting | Neoplasms, Solid Tumor, Breast Neoplasms, Lung Neoplasms, Stomach Neoplasms, Uterine Cervical Neoplasms, Colorectal... | 3,250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07741435) |
| July 14, 2026 | NCT07702721 | Intraoperative Microscopic Assessment of Lymph Node Status in Gynecological Malignancies | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Not yet recruiting | Gynecologic Cancer, Cervical Cancer, Endometrial Cancer, Ovary Cancer, Vulvar Cancer | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07702721) |
| July 10, 2026 | NCT07696169 | Disease Evolution and Risk Factors of AIDS-related Prevalent Cancers | Shenzhen Third People's Hospital | Observational | Not yet recruiting | HIV (Human Immunodeficiency Virus), AIDS, Kaposi Sarcoma (KS), Lymphoma, AIDS-Related Malignancy, Lung Cancer in the... | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07696169) |
| June 30, 2026 | NCT07676461 | Oral, Fecal and Intratumoral Microbiome Atlas in Colombian Patients With Advanced Solid Tumors Receiving First-Line Immunotherapy | Sponsor not shown (see the record) | Observational | Recruiting | Gastric Cancer, Colorectal Cancer, Breast Cancer, Cervical Cancer, Head and Neck Cancer (H&N) | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07676461) |
| June 29, 2026 | NCT07673211 | Circulating cfDNA and HPV as Prognostic Biomarkers for First-Line Recurrent Metastatic Cervical Cancer | Zhejiang Cancer Hospital | Observational | Not yet recruiting | Cervical Cancer, Recurrent Cervical Cancer, Metastatic Cervical Cancer | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07673211) |
| June 24, 2026 | NCT07667192 | Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer | Affidea Nu-med Center of Oncological DIagnostics and Therapy | Observational | Recruiting | Recurrent Gynecologic Cancer, Recurrent Uterine Cancer, Recurrent Cervical Cancer, Recurrent Vaginal Cancer, Recurrent... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07667192) |
| June 17, 2026 | NCT07652983 | TTE Study of QL1706 in Recurrent/Metastatic Cervical Cancer | Qilu Hospital of Shandong University | Observational | Not yet recruiting | Recurrent or Metastatic Cervical Cancer | 280 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07652983) |
| May 26, 2026 | NCT07606677 | Peripheral Blood CyTOF Immune Model for Cervical Lesion Detection in HPV16/18+ Women | Women's Hospital School Of Medicine Zhejiang University | Observational | Not yet recruiting | CIN 2/3, Cervical Cancer (Early Detection) | 1,465 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07606677) |
| May 18, 2026 | NCT07593066 | PRIORITY Study in Cervical Cancer | Pontificia Universidad Catolica de Chile | Observational | Not yet recruiting | Cervical Cancer, Cervical Intraepithelial Neoplasia, HPV Infection | 700 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07593066) |
| April 9, 2026 | NCT07520188 | C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the United States | UNC Lineberger Comprehensive Cancer Center | Observational | Not yet recruiting | Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV), Cervical Cancer, Cervical Precancer | 3,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07520188) |
| March 25, 2026 | NCT07493928 | HPV After chemoRadioTherapy | General University Hospital, Prague | Observational | Recruiting | Cervical Cancer Recurrent, Radiotherapy, Cell Free DNA, HPV | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07493928) |
| February 27, 2026 | NCT07435623 | Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study | Tata Memorial Hospital | Observational | Recruiting | Endometrial Cancer, Cervix Cancer | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07435623) |
| February 10, 2026 | NCT07400809 | Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study. | Tata Memorial Hospital | Observational | Recruiting | Chemotherapy, Treatment Compliance, Radiotherapy, Cervix Cancer, Surgery, Recurrent, Metastasis | 350 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07400809) |
| February 6, 2026 | NCT07394413 | Surgical Handling of Fertility-preserving Treatments for Cervical Adenocarcinomas | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Not yet recruiting | Cervical Adenosarcoma | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07394413) |
| February 4, 2026 | NCT07385976 | The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients | Far Eastern Memorial Hospital | Observational | Not yet recruiting | Cervical Cancer, Cervical Intraepithelial Neoplasm, Ovarian Cancer | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07385976) |
| February 2, 2026 | NCT07382505 | Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer | Asan Medical Center | Observational | Not yet recruiting | Uterine Neoplasms, Cervical Cancer | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07382505) |
| February 2, 2026 | NCT07380698 | The Effect of Dose and Storage Conditions of Indocyanine Green on Efficacy and Cost in Sentinel Lymph Node Mapping in Gynecological Cancer | Cukurova University | Observational | Recruiting | Endometrial Cancer, Vulvar Cancers, Cervical Cancer, Indocyanine Green (ICG) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07380698) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 10 |
| Tata Memorial Hospital | 5 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 3 |
| Women's Hospital School Of Medicine Zhejiang University | 3 |
| Fujian Cancer Hospital | 3 |
| Anhui Provincial Hospital | 2 |
| Mayo Clinic | 2 |
| Centre Hospitalier Universitaire de Nīmes | 2 |
| University Medical Center Groningen | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| University of Pretoria | 2 |
| Asan Medical Center | 2 |
| Affidea Nu-med Center of Oncological DIagnostics and Therapy | 2 |
| Peking Union Medical College Hospital | 2 |
| Centre Paul Strauss | 2 |
| Zhejiang Cancer Hospital | 2 |
| University Hospital Tuebingen | 2 |
| Second Affiliated Hospital of Wenzhou Medical University | 1 |
| International Agency for Research on Cancer | 1 |
| Institut Paoli-Calmettes | 1 |
| ZIWIG | 1 |
| University of California, San Diego | 1 |
| General University Hospital, Prague | 1 |
| Beijing Geekgene Technology Co., LTD | 1 |
| University of Aarhus | 1 |

## By country

| Country | Trials |
| --- | --- |
| Italy | 17 |
| China | 17 |
| United States | 14 |
| France | 8 |
| India | 7 |
| Netherlands | 4 |
| Germany | 4 |
| Colombia | 3 |
| Czechia | 3 |
| Denmark | 3 |
| Poland | 3 |
| South Africa | 2 |
| South Korea | 2 |
| Chile | 1 |
| Taiwan | 1 |
| Malawi | 1 |
| Sweden | 1 |
| Bangladesh | 1 |
| Democratic Republic of the Congo | 1 |
| Ghana | 1 |
| Nepal | 1 |
| Pakistan | 1 |
| Sierra Leone | 1 |
| Tanzania | 1 |
| Zambia | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Seafood wholesalers in the United States](https://specstream.ai/data/businesses/seafood-wholesalers/united-states)
- [Immunodermatology practices in the United States](https://specstream.ai/data/businesses/immunodermatology-practices/united-states)
- [Business financing companies in the United States](https://specstream.ai/data/businesses/business-financing-companies/united-states)
- [Social media agencies in the United States](https://specstream.ai/data/businesses/social-media-agencies/united-states)
- [Internet marketing agencies in the United States](https://specstream.ai/data/businesses/internet-marketing-agencies/united-states)
- [Carpet cleaning companies in the United States](https://specstream.ai/data/businesses/carpet-cleaning-companies/united-states)
